Clinical Trials Sponsored by im3D S.p.A.

Total 665 results

Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects (CHF6333 FIH)

Cystic Fibrosis | Non-Cystic Fibrosis Bronchiectasis

Belgium
Chiesi Farmaceutici S.p.A.

Completed

Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients

Chronic Obstructive Pulmonary Disease | Asthma
Chiesi Farmaceutici S.p.A.

Completed

FACTO Study (Foster® As Complete Treatment Option) (FACTO)

Asthmatic Patients

Spain, France, Germany, Netherlands
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients (Imperial)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics (CHF6001_POC2)

Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children (PAED3)

Asthma

Poland, Ukraine
Chiesi Farmaceutici S.p.A.

Completed

A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler

Asthma

United Kingdom
Fidia Farmaceutici s.p.a.

Completed

Hymovis™ Versus Placebo in Knee Osteoarthritis (Hymovis)

Knee Osteoarthritis

United States, Puerto Rico
Janssen-Cilag S.p.A.

Completed

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Human Immunodeficiency Virus; HIV
Janssen-Cilag S.p.A.

Completed

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder
Siena Biotech S.p.A.

Completed

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Huntington's Disease

United States
Lenzi Egisto S.P.A.

Terminated

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Pustulosis of Palms and Soles

Italy
Siena Biotech S.p.A.

Completed

Escalating Dose Study in Healthy Volunteers With SEN0014196

Huntington's Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Terminated

Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup

Croup

Italy
Janssen-Cilag S.p.A.

Completed

A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

Mental Disorders | Brain Diseases | Dementia | Alzheimer Disease
Chiesi Farmaceutici S.p.A.

Completed

Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States
Dompé Farmaceutici S.p.A

Completed

Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation

Lung Transplantation | Ischemia-Reperfusion Injury

United States
Universidad Miguel Hernandez de Elche
Hospital IMED Elche

Recruiting

Development of a Cortical Visual Neuroprosthesis for the Blind (CORTIVIS)

Blindness

Spain
Montecatone Rehabilitation Institute S.p.A.

Recruiting

Hunova® Randomized Controlled Trial for Trunk Control Improvement in Spinal Cord Injured Patients

Spinal Cord Injury

Italy
Montecatone Rehabilitation Institute S.p.A.

Recruiting

Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients

Spinal Cord Injury Cervical

Italy
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function (BALANCE)

Fabry Disease

United States, Netherlands, Hungary, United Kingdom, Czechia, Norway, Slovenia, Spain, Finland, France, Italy, Switzerland
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients

Fabry Disease

United States, Serbia, Spain, United Kingdom, Australia, Paraguay
Philogen S.p.A.
Boehringer Ingelheim

Completed

Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (PHIBI)

Acute Myeloid Leukemia (AML) Relapse

Germany
Chiesi Farmaceutici S.p.A.
Cromsource

Completed

Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis (rhLaman-08)

Alpha-Mannosidosis

France, Denmark, Austria, Germany, Italy
Kamada, Ltd.
Kedrion S.p.A.

Completed

Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies

Rabies

United States
Nathura S.p.A
Evidilya S.r.l.

Completed

A New Class IIb MD in Proctological Disorders

Proctological Disorders

Italy
Chiesi Farmaceutici S.p.A.
Cromsource

Completed

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

Kidney Transplantation

Italy
Montecatone Rehabilitation Institute S.p.A.

Completed

Locomotor Training With Exoskeleton EKSO-GT in Patients With Incomplete Motor Spinal Cord Injury in a Hospital Setting

Spinal Cord Injuries

Italy
Theravance Biopharma
Alfasigma S.p.A.

Completed

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Gastroparesis

United States
sigma-tau i.f.r. S.p.A.

Completed

Propionyl-L-Carnitine in Ulcerative Colitis

Ulcerative Colitis

Italy, Lithuania, Poland, Russian Federation
Philogen S.p.A.
Eudax S.r.l.

Completed

A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer

Cancer

Italy
sigma-tau i.f.r. S.p.A.

Completed

Efficacy of Rostafuroxin in the Treatment of Essential Hypertension

Essential Hypertension

Belgium
International Biomedical Systems S.p.A.

Unknown

European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent (MARTIN)

Coronary Artery Disease | Angioplasty, Transluminal, Percutaneous Coronary | Stents

Germany, Italy, Netherlands, Switzerland
Pharmanutra S.p.a.
Latis S.r.l.

Not yet recruiting

Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Adjuvant Chemotherapy

Breast Cancer | Fatigue

Italy
Dompé Farmaceutici S.p.A
Covance

Completed

Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers (NGF0112)

Healthy

Switzerland, United Kingdom
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)

Fabry Disease

Australia, Netherlands, United Kingdom, Canada, Czechia, Norway, Slovenia
Montecatone Rehabilitation Institute S.p.A.

Withdrawn

Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients (T-PEP)

Spinal Cord Injury Cervical

Italy
Montecatone Rehabilitation Institute S.p.A.

Completed

Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients

Spinal Cord Injuries | Pressure Ulcer

Italy
Dompé Farmaceutici S.p.A
Cromsource

Completed

Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma (NGF-Glaucoma)

Glaucoma

United States
Montecatone Rehabilitation Institute S.p.A.

Terminated

tDCS in Patients With Disorder of Consciousness Due to Severe Acquired Brain Injury

Brain Injuries | Cognitive Impairment | Consciousness Disorders | Minimally Conscious State | Vegetative State

Italy
sigma-tau i.f.r. S.p.A.

Terminated

Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis

Ulcerative Colitis

Netherlands, Romania, Israel, Czech Republic, Italy, Belgium, Russian Federation, Slovakia
sigma-tau i.f.r. S.p.A.

Completed

A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine

END STAGE RENAL DISEASE

Italy
sigma-tau i.f.r. S.p.A.

Completed

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Malignant Melanoma

France, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
International Biomedical Systems S.p.A.

Unknown

Assessment of the Numen Stent With Evaluation in a Randomized Study (ANSWERS)

Lesion

France
Guerbet
Bracco Imaging S.p.A.

Recruiting

Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

CNS Lesion | Lesion in Body Region

Japan
Nathura S.p.A
Evidilya S.r.l.

Recruiting

Performance and Safety of Class IIb MD Celegyn® in VVA

Vulvovaginal Atrophy

Italy
Alfasigma S.p.A.
bioRASI, LLC

Completed

Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea

Papulopustular Rosacea

United States
Dompé Farmaceutici S.p.A
Cromsource

Completed

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

Healthy Volunteers

United States
Giuliani S.p.A
FitBiomics, Inc.

Completed

Efficacy of a Mix of Probiotics in Athletes Performance (GIU-PPA-0420)

Healthy

Italy

3

Subscribe